Mental health
Ketamine
Treatment named in the FAA's anxiety and depression decision tool
Examiner
FAA review required; the examiner defers
The FAA's anxiety and depression decision tool for the examiner asks about any history of any form of ketamine therapy, alongside electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS) and psychedelic therapy.
Track your medicationsCompare FAA documents: ketamineWhat each of the two FAA documents says, in plain wordsOpen
If any single item is answered YES, the examiner must defer and note what caused the deferral. The Fast Track pathway's copy of the same question says that with any YES the individual does not qualify for the Fast Track pathway. Esketamine (Spravato) has its own entry.
Show the FAA's words: ketamineThe official FAA wording: two passages, each with its document and dateOpen
Only uncomplicated anxiety, depression, and related conditions will qualify for this pathway.
4. Any history of any forms of the following treatment modalities: Electroconvulsive (ECT), Transcranial Magnetic Stimulation (TMS), Ketamine, or Psychedelic therapy?
*If ANY SINGLE ITEM falls into the “YES”/SHADED COLUMN, the AME MUST DEFER. The AME report should note what aspect caused the deferral and explain any YES answers.
4. Any history of any forms of the following treatment modalities: Electroconvulsive (ECT), Transcranial Magnetic Stimulation (TMS), Ketamine, or Psychedelic therapy?
If any items fall into the “YES” column, STOP. The individual does not qualify for the FAST TRACK pathway.